1356600-47-9

Basic information

• Product Name: methyl (4-{4-[(4-{[(2Z)-2-(methoxyimino)-2-phenylethyl]oxy}benzyl)oxy]phenyl}-3-methyl-1,2-oxazol-5-yl)acetate
• CAS NO: 1356600-47-9
• Molecular Weight: 500.551
• Mol File: 1356600-47-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl (4-{4-[(4-{[(2Z)-2-(methoxyimino)-2-phenylethyl]oxy}benzyl)oxy]phenyl}-3-methyl-1,2-oxazol-5-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (4-{4-[(4-{[(2Z)-2-(methoxyimino)-2-phenylethyl]oxy}benzyl)oxy]phenyl}-3-methyl-1,2-oxazol-5-yl)acetate(1356600-47-9)
• EPA Substance Registry System: methyl (4-{4-[(4-{[(2Z)-2-(methoxyimino)-2-phenylethyl]oxy}benzyl)oxy]phenyl}-3-methyl-1,2-oxazol-5-yl)acetate(1356600-47-9)

Safety Data

• Hazardous Substances Data: 1356600-47-9(Hazardous Substances Data)

Upstream product

• 1356600-44-6 methyl 2-(4-iodo-3-methylisoxazol-5-yl)acetate 
• 142533-52-6 (Z)-2-bromo-1-phenylethanone O-methyl oxime 
• 27349-40-2 3-Methyl-isoxazol-5-yl-acetic acid methyl ester 
• 19668-85-0 2-(3-methylisoxazol-5-yl)acetic acid 
• 70-11-1 α-bromoacetophenone 

Relevant articles and documents

AGONISTS OF GPR40

The present invention relates to compounds that have the ability to modulate the activity of GPR40 and are there-fore useful in the treatment of GPR40 related disorders. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders related to GPR40 activity.